Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice

HPB

Volumn 12, Issue 6, 2010, Pages 403-411

  Barreto, Savio G ^a   Carati, Colin J ^b   Schloithe, Ann C ^a   Toouli, James ^a   Saccone, Gino T P ^b  

^a Department of General and Digestive Surgery ^*  (United States)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Inflammation; Peptide; Somatostatin

Indexed keywords

AMYLASE; CERULETIDE; ENZYME; GALANIN RECEPTOR; GALANTIDE; MYELOPEROXIDASE; OCTREOTIDE; RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOLOGY; MALE; MOUSE; NONHUMAN; PANCREAS;

EID: 77956931050     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00191.x     Document Type: Article

References (46)

1. Barreto SG, Rodrigues J. (2008) Acute pancreatitis in Goa - a hospitalbased study. J Indian Med Assoc 106:575-576; discussion 578.
2. Braganza JM. (2001) Towards a novel treatment strategy for acute pancreatitis. 2. Principles and potential practice. Digestion 63:143-162.
3. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT. (2010) The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice. Peptides 26:315-321.
4. Bhandari M, Thomas A, Carati C, Kawamoto M, Toouli J, Saccone G. (2006) Galanin antagonism modifies hyperenzymaemia and pancreatic vascular perfusion (PVP) changes induced by acute pancreatitis (AP) in a possum model. Pancreas 33:447-448.
5. Bhandari M, Thomas AC, Hussey DJ, Li X, Jaya SP, Woods CM et al. (2010) Galanin mediates the pathogenesis of caerulein-induced acute pancreatitis in the mouse. Pancreas 39:182-187.
6. Brooke-Smith ME, Carati CJ, Bhandari M, Toouli J, Saccone GT. (2008) Galanin in the regulation of pancreatic vascular perfusion. Pancreas 36:267-273.
7. Kawamoto M, Bhandari M, Thomas A, Carati C, Toouli J, Saccone G. (2007) The galanin antagonists galantide and M35 but not M40 ameliorate caerulein-induced acute pancreatitis in mice. Pancreatology 7:231.
8. Lindskog S, Ahren B, Land T, Langel U, Bartfai T. (1992) The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 210:183-188.
9. Baxter JN, Jenkins SA, Day DW, Roberts NB, Cowell DC, Mackie CR et al. (1985) Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg 72:382-385.
10. Chen CC, Wang SS, Tsay SH, Lee FY, Wu SL, Lu RH et al. (1998) Effects of high dose octreotide on retrograde bile salt-induced pancreatitis in rats. Peptides 19:543-547.
11. Marton J, Szasz Z, Nagy Z, Jarmay K, Takacs T, Lonovics J et al. (1998) Beneficial effect of octreotide treatment in acute pancreatitis in rats. Int J Pancreatol 24:203-210.
12. Zhu ZH, Holt S, el-Lbishi MS, Grady T, Taylor TV, Powers RE. (1991) A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat. Pancreas 6:609-613.
13. Salem MZ, Cunha JE, Coelho AM, Sampietri SN, Machado MC, Penteado S et al. (2003) Effects of octreotide pretreatment in experimental acute pancreatitis. Pancreatology 3:164-168.
14. Sanchez J, Garcia JL, Gil JS, Oses AV, Coma del Corral MJ, Puerta CV et al. (1997) Octreotide: effects in experimental severe acute pancreatitis. Analysis of survival, biochemical findings and histomorphometry. Rev Esp Enferm Dig 89:101-115.
15. Tulassay Z, Kisfalvi K, Papp M. (1995) The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats. Z Gastroenterol 33:99-102.
16. McGregor DP. (2008) Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 8:616-619.
17. Niederau C, Ferrell LD, Grendell JH. (1985) Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 88 (5 Pt 1):1192-1204.
18. Rifai Y, Elder AS, Carati CJ, Hussey DJ, Li X, Woods CM et al. (2008) The tripeptide analogue feG ameliorates severity of acute pancreatitis in a caerulein mouse model. Am J Physiol Gastrointest Liver Physiol 294:1094-1099.
19. Yuan Y, Gong Z, Lou K, Tu S, Di Z, Xu J. (2001) Effects and mechanisms of somatostatin analogues on apoptosis of pancreatic acinar cells in acute pancreatitis in mice. J Gastroenterol Hepatol 16:683-688.
20. Bhatia M, Brady M, Zagorski J, Christmas SE, Campbell F, Neoptolemos JP et al. (2000) Treatment with neutralizing antibody against cytokineinduced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 47:838-844.
21. Moore-Olufemi SD, Xue H, Attuwaybi BO, Fischer U, Harari Y, Oliver DH et al. (2005) Resuscitation-induced gut oedema and intestinal dysfunction. J Trauma 58:264-270.
22. Howard C, Reed M. (2000) Unbiased Stereology, Three-Dimensional Measurement in Microscopy. Oxford: Bio Scientific 20-65.
23. Toh SK, Phillips S, Johnson CD. (2000) A prospective audit against national standards of the presentation and management of acute pancreatitis in the south of England. Gut 46:239-243.
24. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT. (2009) Galanin potentiates supramaximal caerulein-stimulated pancreatic amylase secretion via its action on somatostatin secretion. Am J Physiol Gastrointest Liver Physiol 297:1268-1273.
25. Cuthbertson CM, Christophi C. (2006) Disturbances of the microcirculation in acute pancreatitis. Br J Surg 93:518-530.
26. Hegyi P, Rakonczay Z Jr, Sari R, Gog C, Lonovics J, Takacs T et al. (2004) L-arginine-induced experimental pancreatitis. World J Gastroenterol 10:2003-2009.
27. Li G, Currie RW, Ali IS. (2004) Insulin potentiates expression of myocardial heat shock protein 70. Eur J Cardiothorac Surg 26:281-288.
28. Ting LP, Tu CL, Chou CK. (1989) Insulin-induced expression of human heat-shock protein gene hsp70. J Biol Chem 264:3404-3408.
29. Tobe K, Asai S, Matuoka K, Yamamoto T, Chida K, Kaburagi Y et al. (2003) Cytoskeletal reorganization induced by insulin: involvement of Grb2/Ash, Ras and phosphatidylinositol 3-kinase signalling. Genes Cells 8:29-40.
30. Schmidhuber SM, Starr A, Wynick D, Kofler B, Brain SD. (2008) Targeted disruption of the galanin gene attenuates inflammatory responses in murine skin. J Mol Neurosci 34:149-155.
31. Liddle RA, Nathan JD. (2004) Neurogenic inflammation and pancreatitis. Pancreatology 4:551-559; discussion 559-560.
32. Uhl W, Anghelacopoulos SE, Friess H, Buchler MW. (1999) The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion 60 (Suppl. 2):23-31.
33. Di Francesco V, Angelini G, Bovo P, Casarini MB, Filippini M, Vaona B et al. (1996) Effect of octreotide on sphincter of Oddi motility in patients with acute recurrent pancreatitis: a manometric study. Dig Dis Sci 41:2392-2396.
34. Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V et al. (1998) Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12:237-245.
35. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G et al. (2000) Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51:1-7.
36. Guan D, Maouyo D, Sarfati P, Morisset J. (1990) Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats. Endocrinology 127:298-304.
37. Wenger FA, Kilian M, Heukamp I, Foitzik T, Jacobi CA, Guski H et al. (2007) Effects of octreotide in acute haemorrhagic necrotizing pancreatitis in rats. J Gastroenterol Hepatol 22:1872-1876.
38. Cindoruk M, Kayhan B, Gorgul A, Kandilci U. (2001) Comparison of the efficacy of the somatostatin analogue SMS 201-995 and electromagnetic fields in caerulein-induced pancreatitis in rats. Curr Ther Res 62:254-260.
39. Paran H, Klausner J, Siegal A, Graff E, Freund U, Kaplan O. (1996) Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats. J Surg Res 62:201-206.
40. Jenkins SA, Nott DM, Baxter JN. (1995) Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae. Eur J Gastroenterol Hepatol 7:255-258.
41. Garvin PJ, Burton FR, Reese JC, Dysarz FA III, Lingle D, Niehoff ML et al. (1996) Effect of somatostatin and octreotide acetate on OP-CCKstimulated exocrine secretion in the denervated canine pancreas. Pancreas 13:304-310.
42. Singh J, Adeghate E, Salido GM, Pariente JA, Yago MD, Juma LO. (1999) Interaction of islet hormones with cholecystokinin octapeptide-evoked secretory responses in the isolated pancreas of normal and diabetic rats. Exp Physiol 84:299-318.
43. Kolasinski SL, Haines KA, Siegel EL, Cronstein BN, Abramson SB. (1992) Neuropeptides and inflammation. A somatostatin analogue as a selective antagonist of neutrophil activation by substance P. Arthritis Rheum 35:369-375.
44. Lau D, Baldus S. (2006) Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111:16-26.
45. Chao TC, Cheng HP, Walter RJ. (1995) Somatostatin and macrophage function: modulation of hydrogen peroxide, nitric oxide and tumour necrosis factor release. Regul Pept 58:1-10.
46. Jenkins SA, Baxter JN, Day DW, Al-Sumidaie AM, Leinster SJ, Shields R. (1986) The effects of somatostatin and SMS 201-995 on experimentally induced pancreatitis and endotoxaemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klin Wochenschr 64 (Suppl. 7):100-106